International Association of Diabetes and Pregnancy Study Groups

International Association of Diabetes and Pregnancy Study Groups
Name	International Association of Diabetes and Pregnancy Study Groups
Abbreviation	IADPSG
Formation	2010
Headquarters	Geneva
Region served	Worldwide

Contents

International Association of Diabetes and Pregnancy Study Groups is a multinational consortium formed to harmonize diagnostic approaches to hyperglycemia in pregnancy and to translate research into clinical guidelines. The group convenes experts from leading institutions such as World Health Organization, International Diabetes Federation, American Diabetes Association, European Association for the Study of Diabetes, and Royal College of Obstetricians and Gynaecologists to produce consensus recommendations. Its work intersects with major clinical trials, professional societies, and public health bodies including National Institutes of Health, Centers for Disease Control and Prevention, University of Oxford, Harvard University, and Johns Hopkins University.

History

The association was established following collaborative studies involving investigators from Hyperglycemia and Adverse Pregnancy Outcome Study, University of Toronto, Royal Prince Alfred Hospital, McMaster University, and research centers tied to National Health Service (England and Wales), University of Sydney, University of Copenhagen, and Karolinska Institute. Early meetings included representatives from International Federation of Gynecology and Obstetrics, Endocrine Society (United States), Perinatal Society of Australia and New Zealand, and delegations associated with Bill & Melinda Gates Foundation-funded maternal health initiatives. The formation was catalyzed by data syntheses and statistical analyses performed by teams at World Health Organization, World Bank, European Commission, and academic groups at Stanford University and Massachusetts General Hospital.

The association aims to standardize screening and diagnostic thresholds for gestational diabetes mellitus through consensus among clinical organizations such as American College of Obstetricians and Gynecologists, Canadian Diabetes Association, Society for Maternal-Fetal Medicine, Australasian Diabetes in Pregnancy Society, and Society of Obstetricians and Gynaecologists of Canada. Objectives include producing evidence-based criteria, informing guideline panels at Royal College of Physicians, advising policy at Ministry of Health (United Kingdom), and supporting capacity building in settings served by United Nations Children's Fund, United Nations Population Fund, and regional health authorities like Pan American Health Organization.

The association published algorithms and glucose thresholds derived from pooled analyses that influenced recommendations by World Health Organization and were debated by professional bodies including American Diabetes Association, European Association for the Study of Diabetes, International Federation of Gynecology and Obstetrics, and national guideline panels such as National Institute for Health and Care Excellence and Canadian Task Force on Preventive Health Care. Its criteria encompass oral glucose tolerance testing protocols that reference laboratory standards promulgated by College of American Pathologists, International Organization for Standardization, and consultative input from clinical leaders at Mayo Clinic, Cleveland Clinic, and Karolinska University Hospital. Implementation discussions have involved public health agencies like Centers for Disease Control and Prevention and research networks at Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Association working groups have authored consensus statements, guideline papers, and methodological reports appearing in journals associated with institutions such as The Lancet, New England Journal of Medicine, Diabetes Care, British Medical Journal, and American Journal of Obstetrics and Gynecology. Collaborative research has linked cohorts from Framingham Heart Study-related investigators, longitudinal studies at Imperial College London, and cohort analyses coordinated with China CDC and All India Institute of Medical Sciences. Methodological contributions drew on biostatistical expertise from Johns Hopkins Bloomberg School of Public Health, University College London, and University of California, San Francisco.

Adoption of the association’s recommendations has varied across systems including national programs in Australia, Canada, United Kingdom, United States, India, China, and nations within the European Union and African Union. Implementation efforts have been supported by training collaborations with World Health Organization, operational research funded through partnerships with Bill & Melinda Gates Foundation and Wellcome Trust, and service integration projects with Médecins Sans Frontières. Policy debates occurred in forums such as meetings at United Nations, regional workshops of Pan American Health Organization, and technical consultations with Ministry of Health and Welfare (Japan) and Federal Ministry of Health (Nigeria).

The association operates through an executive committee, chairs from specialty societies like American College of Obstetricians and Gynecologists and Endocrine Society (United States), and working groups comprising clinicians and investigators from institutions including Harvard Medical School, Yale School of Medicine, University of Melbourne, University of Toronto, and Seoul National University. Membership spans professionals affiliated with hospitals such as Mount Sinai Hospital (New York), Toronto General Hospital, Royal Women’s Hospital, Melbourne, and universities like Peking University and University of Cape Town. Liaison relationships exist with regulatory and advisory bodies including World Health Organization, International Diabetes Federation, and national ministries of health.

Category:Medical organizations